GoKawiilViatris Acquires Pacira BioSciences in $1.65 Billion Deal
Viatris announced its plan to acquire Pacira BioSciences for $1.65 billion, aiming to broaden its range of pain management medicines. The deal signifies a strategic move to enhance Viatris's portfolio in the healthcare sector.